29 related articles for article (PubMed ID: 23574384)
1. Lnc-PLCB1 is stabilized by METTL14 induced m6A modification and inhibits Helicobacter pylori mediated gastric cancer by destabilizing DDX21.
Chang M; Cui X; Sun Q; Wang Y; Liu J; Sun Z; Ren J; Sun Y; Han L; Li W
Cancer Lett; 2024 Apr; 588():216746. PubMed ID: 38387756
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Noxa-mediated apoptosis in Helicobacter pylori-infected gastric epithelial cells.
Rath S; Das L; Kokate SB; Pratheek BM; Chattopadhyay S; Goswami C; Chattopadhyay R; Crowe SE; Bhattacharyya A
FASEB J; 2015 Mar; 29(3):796-806. PubMed ID: 25404713
[TBL] [Abstract][Full Text] [Related]
3. Roles of Eicosanoids in Regulating Inflammation and Neutrophil Migration as an Innate Host Response to Bacterial Infections.
Sheppe AEF; Edelmann MJ
Infect Immun; 2021 Jul; 89(8):e0009521. PubMed ID: 34031130
[TBL] [Abstract][Full Text] [Related]
4. Anti-cancer effect of low dose of celecoxib may be associated with lnc-SCD-1:13 and lnc-PTMS-1:3 but not COX-2 in NCI-N87 cells.
Song B; Shu ZB; Du J; Ren JC; Feng Y
Oncol Lett; 2017 Aug; 14(2):1775-1779. PubMed ID: 28789408
[TBL] [Abstract][Full Text] [Related]
5. Co-expressed differentially expressed genes and long non-coding RNAs involved in the celecoxib treatment of gastric cancer: An RNA sequencing analysis.
Song B; Du J; Feng Y; Gao YJ; Zhao JS
Exp Ther Med; 2016 Oct; 12(4):2455-2468. PubMed ID: 27698747
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways.
Yong X; Tang B; Li BS; Xie R; Hu CJ; Luo G; Qin Y; Dong H; Yang SM
Cell Commun Signal; 2015 Jul; 13():30. PubMed ID: 26160167
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib inhibits CD133-positive cell migration via reduction of CCR2 in Helicobacter pylori-infected Mongolian gerbils.
Futagami S; Hamamoto T; Shimpuku M; Nagoya H; Kawagoe T; Horie A; Shindo T; Gudis K; Sakamoto C
Digestion; 2010; 81(3):193-203. PubMed ID: 20090335
[TBL] [Abstract][Full Text] [Related]
8. Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions.
Zhang LJ; Wang SY; Huo XH; Zhu ZL; Chu JK; Ma JC; Cui DS; Gu P; Zhao ZR; Wang MW; Yu J
World J Gastroenterol; 2009 Jun; 15(22):2731-8. PubMed ID: 19522023
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils.
Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Tatsuguchi A; Ueki N; Shinji Y; Kusunoki M; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
Digestion; 2006; 74(3-4):187-98. PubMed ID: 17341852
[TBL] [Abstract][Full Text] [Related]
10. Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study.
Aziz F; Yang X; Wang X; Yan Q
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1221-35. PubMed ID: 25527419
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib inhibits apurinic/apyrimidinic endonuclease-1 expression and prevents gastric cancer in Helicobacter pylori-infected mongolian gerbils.
Futagami S; Kawagoe T; Horie A; Shindo T; Hamamoto T; Suzuki K; Kusunoki M; Miyake K; Gudis K; Tsukui T; Crowe SE; Sakamoto C
Digestion; 2008; 78(2-3):93-102. PubMed ID: 18987470
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib inhibits Helicobacter pylori-induced invasion of gastric cancer cells through an adenine nucleotide translocator-dependent mechanism.
Lan C; Yang L; Fan L; Zhang Y; Wang J; Guo GJ; Wan S; Yang S; Wang R; Fang D
Anticancer Agents Med Chem; 2013 Oct; 13(8):1267-72. PubMed ID: 23574384
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive effect of celecoxib in gastric cancer.
Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Ueki N; Kusunoki M; Miyake K; Gudis K; Tsukui T; Sakamoto C
Inflammopharmacology; 2007 Feb; 15(1):1-4. PubMed ID: 17323186
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
